Proof of Concept of an Anaplerotic Study Using Brain Phosphorus Magnetic Resonance Spectroscopy in Huntington Disease
PHASE2CompletedINTERVENTIONAL
Enrollment
10
Participants
Timeline
Start Date
May 31, 2013
Primary Completion Date
July 31, 2013
Study Completion Date
July 31, 2013
Conditions
Huntington Disease
Interventions
DRUG
Triheptanoin 1g/kg/day
Trial Locations (1)
75013
Brain and Spine Institute, Paris
All Listed Sponsors
lead
Institut National de la Santé Et de la Recherche Médicale, France
OTHER_GOV
NCT01882062 - Proof of Concept of an Anaplerotic Study Using Brain Phosphorus Magnetic Resonance Spectroscopy in Huntington Disease | Biotech Hunter | Biotech Hunter